FDA Alert: Pain Relief Dietary Supplements Recalled Due to Presence of Diclofenac

This is a reprint of an FDA Alert.

Botanical-Be Issues Voluntary Nationwide Recall of Kuka Flex Forte, Artri King, and Reumo Flex (Capsules.) Due to Presence of Undeclared Diclofenac

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.

October 23, 2023


Company Announcement Date:  October 22, 2023

FDA Publish Date: October 23, 2023

Product Type: Dietary Supplements

Reason for Announcement: Undeclared drug, Diclofenac

Company Name: Botanical-Be

Brand Name: Multiple brands

Product Description: Dietary Supplements with undeclared Diclofenac

Company Announcement


FOR IMMEDIATE RELEASE – October 22, 2023 – El Paso, TX. Botanical-Be is voluntarily recalling of all lots of Kuka Flex Forte, Capsules, Artri King, Capsules, and Reumo Flex, Capsules to the consumer level. FDA analysis has found the Kuka Flex Forte, capsules, Artri King, capsules, and Reumo Flex, capsules, to be tainted with Diclofenac. Diclofenac is an approved non-steroidal anti-inflammatory drug (NSAID), the presence of Diclofenac in Kuka Flex Forte, Artri King, and Reumo Flex renders them unapproved drugs for which safety and efficacy have not been established and, therefore, subject to recall.

Risk Statement: Consumption of undeclared diclofenac could result in serious adverse events that include cardiovascular, gastrointestinal, renal, and anaphylaxis in patients taking concomitant NSAIDs and/or anticoagulants, such as Warfarin, in those who have allergies to diclofenac, or those with underlying cardiovascular, gastrointestinal, renal, and hepatic illnesses. To date, Botanical-Be has not received any reports of adverse events related to this recall.

These tainted products are marketed as a dietary supplement for relief of pain and inflammation associated with arthritis and are packaged as followed:

  • Artri king distribute in the bottles with 100 capsules.
  • Kuka Flex distribute in the bottles with 30 capsules.
  • Reumo flex distribute in the boxes with 30 capsules.

The affected product lots include the following lot numbers and expirations: Artri King lot 35421, with an expiration date of December 19, 2025; Kuka Flex Forte; all lots with an expiration date of December 12, 2024, and UPC code 0736640810265; Reumo Flex; all lots with an expiration date of October 20, 2024. These products were distributed nationwide via the internet.

Botanical-Be is notifying its customers via email and is arranging for the return of all recalled products. Consumers in possession of these products should cease usage immediately and return them to the place of purchase.

For any queries related to this recall, consumers can contact Botanical-Be by phone at (915) 412-6237 or by e-mail at botanical.be AT gmail.com on Monday to Friday from 8:00 am to 5:pm, Mountain standard time. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.



Company Contact Information




Product Photos